Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for advanced thyroid cancer: drug shows tumor-shrinking promise

NCT ID NCT00510640

Completed Disease control Sponsor: University Hospital, Bordeaux Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested the drug sunitinib (Sutent) in 71 people with advanced thyroid cancer that had spread or could not be removed by surgery. The goal was to see if the drug could shrink tumors when standard treatments like radioactive iodine no longer work. Participants took sunitinib pills, and researchers measured how many had their tumors shrink or disappear.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANAPLASTIC THYROID CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer differentiated thyroid carcinoma familial medullary thyroid carcinoma neoplasm thyroid gland carcinoma thyroid gland undifferentiated (anaplastic) carcinoma Thyroid Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER THYROID CARCINOMA

Contacts and locations

Locations

  • Centre Antoine Lacassagne - 33 avenue de Valombrose

    Nice, 06189, France

  • Centre Léon Bérard - Département de Médecine - 28 rue Laennec

    Lyon, 69373, France

  • Centre Paul Lamarque - Va d'Aurelle - CRLC Val d'Aurelle - 208 rue des Apothicaires

    Montpellier, 34298, France

  • Centre Paul Papin - 2 rue Moll

    Angers, 49100, France

  • Département Endocrinolo-Diabéto-Nutrition - CHU d'Angers - 4 rue de Larray

    Angers, 49933, France

  • Fédération Endocrinologie - Groupe Hospitalier Est - Hôpital neurologique - CHU Lyon - 59 Boulevard Pinel

    Bron, 69677, France

  • Service d'Endocrinologie - CHU de Nancy, Hôpital de Brabois - rue du Morvan

    Vandœuvre-lès-Nancy, 54511, France

  • Service d'Endocrinologie - Hôpital de l'Archet I - Route Saint Antoine de Jinestière

    Nice, 06202, France

  • Service d'Endocrinologie et maladies métaboliques, Clinique Marc Linquette - rue du Pr Laguesse

    Lille, 59037, France

  • Service d'Endocrinologie, CHU Timone, AP-HM - 254 rue St Pierre

    Marseille, 13385, France

  • Service d'Oncologie Médicale et de Radiothérapie - Hôpital Saint André - 1 rue Jean Burguet

    Bordeaux, 33075, France

  • Service d'Oncologie Médicale, Institut Claudius Regaud - 20-24 rue du Pont Saint Pierre

    Toulouse, 31052, France

  • Service d'endocrinologie et Maladies Métaboliques, Groupe Hospitalier Rangueil-Larrey CHU Toulouse - avenue Prof Jean Poulhes

    Toulouse, 31059, France

  • Service de Cancérologie Médicale - HEGP - 20 rue Leblanc

    Paris, 75015, France

  • Service des Maladies Endocriniennes - Hôpital Lapeyronie - 191 avenue du Doyen Gaston Giraud

    Montpellier, 34295, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.